v3.26.3
Summary of significant accounting policies (Details Narrative) - Exascale Labs Inc [Member] - USD ($)
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jan. 08, 2026
Jul. 01, 2022
Jun. 01, 2022
Cash and cash equivalents $ 2,693,586 $ 4,231,689      
Current liabilities 31,885,500 20,319,721      
Cash for operating activities (2,754,624) (1,010,799)      
Net loss (12,162,391) (7,659,667)      
Accumulated deficit (25,379,426) (13,217,035)      
Safe liabilities 29,100,000        
Proceeds from safes 11,800,000        
Cash equivalents 0 0      
Receipt of digital assets 991,601        
Disbursement of digital assets 991,601        
Fair value gain or loss on digital assets 0        
Deferred offering costs 190,000      
Allowance for expected credit losses 0 0      
Other receivables 0 1,207,626      
Refundable deposits payable 359,481 1,445,580      
Impairment of long-lived assets 0 0      
Revenues 14,822,799 7,015,512      
Revenue recognized 392,152 95,326      
Advertising and promotion expenses 80,910 $ 157,388      
Common stock, shares authorized   1,500 1,500   1,500
Common stock, par value   $ 0.01   $ 0.01  
Common stock, shares issued   1,500      
Common stock, shares outstanding   1,500      
Dividends $ 0 $ 0      
Class A Common Stock [Member]          
Common stock, shares authorized 303   303    
Class B Common Stock [Member]          
Common stock, shares authorized 1,197   1,197